Caroline Duineveld
Overview
Explore the profile of Caroline Duineveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ter Avest M, Duineveld C, Bouwmeester R, Baas L, van den Heuvel L, Langemeijer S, et al.
Nephrol Dial Transplant
. 2024 Nov;
40(3):598-601.
PMID: 39533120
No abstract available.
2.
Duineveld C, Glover E, Bouwmeester R, van de Kar N, Kavanagh D, Wetzels J, et al.
Transplantation
. 2024 Jul;
109(3):511-518.
PMID: 39049128
Background: Guidelines advise eculizumab prophylaxis for most kidney transplant recipients with atypical hemolytic uremic syndrome (aHUS). However, recurrence rates may be overestimated, and starting eculizumab at relapse ("rescue therapy") may...
3.
Duineveld C, van de Kar N, Wetzels J
Kidney Int Rep
. 2024 May;
9(5):1538.
PMID: 38707808
No abstract available.
4.
Duineveld C, Bouwmeester R, van den Heuvel L, van de Kar N, Wetzels J
Kidney Int Rep
. 2024 Feb;
9(1):145-151.
PMID: 38312782
Introduction: In 2014, a complement assay, which evaluates C5b-9 deposition on endothelial cells, was proposed as a biomarker for atypical hemolytic uremic syndrome (aHUS). Early diagnosis and/or prediction of aHUS...
5.
Gant C, Koelman C, Nguyen T, Abrahams A, Wetzels J, Duineveld C, et al.
Am J Kidney Dis
. 2023 Sep;
83(3):415-419.
PMID: 37734685
Monoclonal gammopathy with cryoactivity (ie, cryoglobulins) that causes glomerulonephritis is considered within the spectrum of monoclonal gammopathy of renal significance. Cryofibrinogenemia (cryoactivity of coagulation factors) is very rarely associated with...
6.
Duineveld C, Bouwmeester R, Wijnsma K, Bemelman F, van der Heijden J, Berger S, et al.
Kidney Int Rep
. 2023 Apr;
8(4):715-726.
PMID: 37069997
Introduction: Since 2016, kidney transplantation in patients with atypical hemolytic uremic syndrome (aHUS) in the Netherlands is performed without eculizumab prophylaxis. Eculizumab is given in case of posttransplant aHUS recurrence....
7.
Ter Avest M, Steenbreker H, Bouwmeester R, Duineveld C, Wijnsma K, van den Heuvel L, et al.
Clin J Am Soc Nephrol
. 2023 Mar;
18(6):759-766.
PMID: 36913245
Background: Eculizumab is a monoclonal antibody for the treatment of atypical hemolytic uremic syndrome (aHUS). Kidney damage, a common condition in patients with aHUS, may result in proteinuria. Because proteinuria...
8.
Bouwmeester R, Duineveld C, Wijnsma K, Bemelman F, van der Heijden J, van Wijk J, et al.
Kidney Int Rep
. 2023 Jan;
8(1):91-102.
PMID: 36644349
Introduction: The introduction of eculizumab has improved the outcome in patients with atypical hemolytic uremic syndrome (aHUS). The optimal treatment strategy is debated. Here, we report the results of the...
9.
Bouwmeester R, Bormans E, Duineveld C, van Zuilen A, Logt A, Wetzels J, et al.
Front Immunol
. 2022 Dec;
13:1056153.
PMID: 36531998
Introduction: COVID-19 vaccination has been associated with rare but severe complications characterized by thrombosis and thrombocytopenia. Methods And Results: Here we present three patients who developed or relapse atypical hemolytic...
10.
Ter Avest M, Bouwmeester R, Duineveld C, Wijnsma K, Volokhina E, van den Heuvel L, et al.
Nephrol Dial Transplant
. 2022 Mar;
38(2):362-371.
PMID: 35238929
Background: Eculizumab is a lifesaving yet expensive drug for atypical haemolytic uraemic syndrome (aHUS). Current guidelines advise a fixed-dosing schedule, which can be suboptimal and inflexible in the individual patient....